Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rehabilitation Centers | 6 | 2017 | 254 | 1.030 |
Why?
|
| Phenol | 2 | 2013 | 43 | 0.910 |
Why?
|
| Patient Transfer | 3 | 2017 | 761 | 0.880 |
Why?
|
| Cancer Care Facilities | 5 | 2017 | 402 | 0.840 |
Why?
|
| Rehabilitation | 3 | 2019 | 134 | 0.820 |
Why?
|
| Inpatients | 7 | 2018 | 2518 | 0.740 |
Why?
|
| Disability Evaluation | 4 | 2018 | 1827 | 0.680 |
Why?
|
| Pelvic Exenteration | 1 | 2017 | 22 | 0.620 |
Why?
|
| Insurance, Disability | 1 | 2017 | 26 | 0.600 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2016 | 23 | 0.570 |
Why?
|
| Nerve Block | 2 | 2013 | 644 | 0.570 |
Why?
|
| Stiff-Person Syndrome | 1 | 2016 | 28 | 0.560 |
Why?
|
| Neoplasms | 15 | 2019 | 21683 | 0.520 |
Why?
|
| Muscle Spasticity | 2 | 2013 | 154 | 0.510 |
Why?
|
| Paraneoplastic Cerebellar Degeneration | 1 | 2014 | 15 | 0.500 |
Why?
|
| Insurance Carriers | 1 | 2016 | 157 | 0.470 |
Why?
|
| Knee | 1 | 2015 | 274 | 0.460 |
Why?
|
| Terminal Care | 2 | 2015 | 1694 | 0.420 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 191 | 0.410 |
Why?
|
| Fatigue | 2 | 2016 | 1531 | 0.390 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1179 | 0.360 |
Why?
|
| Palliative Care | 4 | 2018 | 3493 | 0.350 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2012 | 213 | 0.340 |
Why?
|
| Pain | 2 | 2015 | 4986 | 0.340 |
Why?
|
| Leukemia | 2 | 2013 | 1511 | 0.310 |
Why?
|
| Lymphoma | 2 | 2013 | 1877 | 0.300 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 1439 | 0.300 |
Why?
|
| Hospitalization | 7 | 2018 | 10262 | 0.280 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 1620 | 0.280 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1855 | 0.270 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1832 | 0.270 |
Why?
|
| Hemorrhage | 1 | 2018 | 3461 | 0.270 |
Why?
|
| Astrocytoma | 1 | 2010 | 790 | 0.260 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 1513 | 0.250 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2765 | 0.240 |
Why?
|
| Carcinoma | 1 | 2014 | 2375 | 0.210 |
Why?
|
| Retrospective Studies | 15 | 2018 | 77449 | 0.210 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 5181 | 0.200 |
Why?
|
| Primary Health Care | 2 | 2017 | 4558 | 0.190 |
Why?
|
| Physical Therapy Modalities | 2 | 2015 | 550 | 0.190 |
Why?
|
| Fellowships and Scholarships | 2 | 2019 | 1076 | 0.180 |
Why?
|
| Length of Stay | 6 | 2018 | 6309 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7279 | 0.180 |
Why?
|
| Platelet Count | 2 | 2013 | 781 | 0.180 |
Why?
|
| Patient Readmission | 1 | 2013 | 3114 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3679 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9239 | 0.170 |
Why?
|
| Middle Aged | 17 | 2018 | 213383 | 0.170 |
Why?
|
| Antifungal Agents | 2 | 2013 | 730 | 0.160 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 288 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 4838 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.150 |
Why?
|
| Activities of Daily Living | 3 | 2018 | 2418 | 0.150 |
Why?
|
| Brain Neoplasms | 3 | 2016 | 8863 | 0.140 |
Why?
|
| Female | 20 | 2019 | 380194 | 0.140 |
Why?
|
| Consumer Health Information | 1 | 2018 | 211 | 0.130 |
Why?
|
| Humans | 31 | 2019 | 744343 | 0.130 |
Why?
|
| Subacute Care | 1 | 2017 | 168 | 0.120 |
Why?
|
| Speech Therapy | 1 | 2014 | 57 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7659 | 0.120 |
Why?
|
| Patient Selection | 2 | 2017 | 4215 | 0.120 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
| Quality of Life | 5 | 2017 | 12804 | 0.110 |
Why?
|
| Aged | 10 | 2017 | 163280 | 0.110 |
Why?
|
| Occupational Therapy | 1 | 2014 | 134 | 0.110 |
Why?
|
| Male | 17 | 2019 | 350118 | 0.110 |
Why?
|
| Blast Crisis | 1 | 2013 | 103 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 552 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 523 | 0.100 |
Why?
|
| Hemipelvectomy | 1 | 2011 | 7 | 0.100 |
Why?
|
| Hospital Units | 1 | 2012 | 141 | 0.100 |
Why?
|
| Hospice Care | 1 | 2018 | 672 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2016 | 553 | 0.100 |
Why?
|
| Neuromuscular Agents | 1 | 2012 | 134 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2013 | 2987 | 0.090 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 127 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2017 | 906 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13102 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2017 | 63114 | 0.090 |
Why?
|
| Injections | 1 | 2012 | 840 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 990 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 57776 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2013 | 1588 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 254 | 0.080 |
Why?
|
| Survivors | 2 | 2015 | 2291 | 0.080 |
Why?
|
| Logistic Models | 2 | 2013 | 13408 | 0.080 |
Why?
|
| Incidence | 2 | 2017 | 20947 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1919 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20822 | 0.070 |
Why?
|
| Internet | 1 | 2018 | 3064 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2017 | 23338 | 0.070 |
Why?
|
| Curriculum | 1 | 2018 | 3605 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3610 | 0.060 |
Why?
|
| Caregivers | 1 | 2017 | 2094 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1671 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3843 | 0.060 |
Why?
|
| Adult | 8 | 2018 | 214055 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3528 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2016 | 3313 | 0.050 |
Why?
|
| Movement | 1 | 2010 | 1471 | 0.050 |
Why?
|
| Young Adult | 3 | 2013 | 56430 | 0.050 |
Why?
|
| Recovery of Function | 3 | 2018 | 2925 | 0.050 |
Why?
|
| Glioma | 1 | 2016 | 3401 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2015 | 3481 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 29063 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5317 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5102 | 0.040 |
Why?
|
| United States | 5 | 2019 | 69872 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7181 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 40561 | 0.030 |
Why?
|
| Specialization | 1 | 2018 | 777 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 40075 | 0.030 |
Why?
|
| Cognition | 1 | 2010 | 6770 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39050 | 0.030 |
Why?
|
| Self Care | 1 | 2017 | 786 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2015 | 921 | 0.020 |
Why?
|
| Child | 2 | 2011 | 77709 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 85781 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2576 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2019 | 4687 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3420 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53288 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15295 | 0.010 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_